BALDUZZI, SILVIA
 Distribuzione geografica
Continente #
NA - Nord America 288
EU - Europa 184
AS - Asia 49
SA - Sud America 1
Totale 522
Nazione #
US - Stati Uniti d'America 287
IE - Irlanda 124
CN - Cina 48
IT - Italia 23
DE - Germania 13
FI - Finlandia 13
BE - Belgio 6
RU - Federazione Russa 2
SE - Svezia 2
BR - Brasile 1
CA - Canada 1
IR - Iran 1
RO - Romania 1
Totale 522
Città #
Dublin 122
Chandler 70
Ashburn 51
Lawrence 13
Medford 13
Princeton 13
Helsinki 12
Nanjing 12
New York 12
Shanghai 11
Beijing 10
Washington 9
Brussels 6
Wilmington 5
Galliate 4
Nanchang 4
Norwalk 4
Seattle 4
Changsha 3
Milan 3
Pavia 3
Ann Arbor 2
Berlin 2
Fairfield 2
Hebei 2
Jacksonville 2
Jiaxing 2
Matera 2
Monzambano 2
Shenyang 2
Woodbridge 2
Chicago 1
Guangzhou 1
Gunzenhausen 1
Hangzhou 1
Messina 1
Philadelphia 1
Saint Petersburg 1
Serramanna 1
Toronto 1
Totale 413
Nome #
Methotrexate and glucocorticoids, but not anticytokine therapy, impair the immunogenicity of a single dose of the BNT162b2 mRNA COVID-19 vaccine in patients with chronic inflammatory arthritis 51
Clinical follow-up predictors of disease pattern change in anti-Jo1 positive anti-synthetase syndrome: Results from a multicenter, international and retrospective study 49
In early inflammatory polyarthritis more intensive management according to the 2010 ACR/EULAR criteria leads to higher rates of clinical remission: Comparison of two cohorts treated according to different treat to target protocols 48
Correspondence on 'EULAR December 2020 viewpoints on SARS-CoV-2 vaccination in patients with RMDs' 47
Reactogenicity, safety and disease flares following BNT162b2 mRNA COVID-19 vaccine in patients with chronic immune-inflammatory arthritis treated with biological and targeted synthetic disease-modifying anti-rheumatic drugs 42
Preliminary Validation of the Digital Ulcer Clinical Assessment Score in Systemic Sclerosis 41
The role of extra-corporeal membrane oxygenation (ECMO) in the treatment of diffuse alveolar haemorrhage secondary to ANCA-associated vasculitis: report of two cases and review of the literature 39
Impact of smoking habit on adult-onset Still’s disease prognosis, findings from a multicentre observational study 35
Retention rate of IL-1 inhibitors in Schnitzler's syndrome 33
Prevalence of COVID infections in a population of rheumatic patients from Lombardy and Marche treated with biological drugs or small molecules: A multicentre retrospective study 32
Use of rituximab in a multicentre cohort of patients with rheumatic diseases during the outbreak of novel SARS-COV-2 infection 30
Clinical course of COVID-19 in a series of patients with chronic arthritis treated with immunosuppressive targeted therapies 29
Disparities in the prevalence of clinical features between systemic juvenile idiopathic arthritis and adult-onset Still's disease 26
Incidence of COVID-19 in patients with rheumatic diseases treated with targeted immunosuppressive drugs: what can we learn from observational data? 24
Impact of smoking habit on adult-onset Still's disease prognosis, findings from a multicentre observational study 13
Correction to: Impact of smoking habit on adult-onset Still's disease prognosis, findings from a multicentre observational study 7
Retention rate of a second line with a biologic DMARD after failure of a first-line therapy with abatacept, tocilizumab, or rituximab: results from the Italian GISEA registry 6
Totale 552
Categoria #
all - tutte 2.375
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.375


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20191 0 0 0 0 0 0 0 0 0 0 1 0
2019/202038 12 14 0 0 0 0 0 1 1 5 5 0
2020/202114 0 0 1 0 0 0 1 3 4 0 4 1
2021/202258 0 0 3 1 5 2 2 4 1 2 8 30
2022/2023271 24 26 1 9 15 19 1 14 137 1 9 15
2023/2024159 18 25 12 8 23 47 6 16 4 0 0 0
Totale 552